On the fiftieth anniversary of Prof. Jérôme Lejeune's discovery of the cause of Down syndrome, French daily Le Figaro published an appeal by the Jérôme Lejeune Foundation:
"why does France spend money on screening and nothing on treatment ?".
"In France, there is currently no public policy for therapeutic research on Down syndrome; there is only a public policy for screening."
French medical daily, Le Quotidien du Médecin, also reported on this appeal : "it is conceivable to reduce mental deficiency enough to enable Down syndrome sufferers to be independent and live normally". The appeal is aimed in particular at researchers and decision makers for "France to invest at least as much in treatment research as in screening".
This appeal was published a day after the latest book by Jean-Marie Le Méné, chairman of the Jérôme Lejeune Foundation, was released in book stores : La trisomie est une tragédie grecque (Down Syndrome is a Greek Tragedy), published by Salvator.
Source: Contact Genethique, the online newsletter of the Fondation Lejeune in Paris.
"why does France spend money on screening and nothing on treatment ?".
"In France, there is currently no public policy for therapeutic research on Down syndrome; there is only a public policy for screening."
French medical daily, Le Quotidien du Médecin, also reported on this appeal : "it is conceivable to reduce mental deficiency enough to enable Down syndrome sufferers to be independent and live normally". The appeal is aimed in particular at researchers and decision makers for "France to invest at least as much in treatment research as in screening".
This appeal was published a day after the latest book by Jean-Marie Le Méné, chairman of the Jérôme Lejeune Foundation, was released in book stores : La trisomie est une tragédie grecque (Down Syndrome is a Greek Tragedy), published by Salvator.
Source: Contact Genethique, the online newsletter of the Fondation Lejeune in Paris.
1 comment:
So great that you noted this! Pray for us Prof. Lejeune!
Post a Comment